- The DNA Methylation Marker ZNF671 Has Prognostic Value for Progressing Cervical Intraepithelial Neoplasia: Lena Dübbel et al, Cancers (2025)
- Prospective Study on Clinical Performance of Host DNA Methylation Assay for Triage in Women Who Are HPV-Positive — 4 Provinces, China, 2018–2021: Jing Zhang et al, China CDC Weekly (2025)
- Analysis of the triage value of multigene methylation testing for CIN2 + in Infectious Agents and Cancer: Caiyun Lin et al, BMC (2025)
- Methylation testing versus cervical cytology for triage of HPV-positive women: A comparative study: Mingyang Wang et al, Diagnostic Microbiology and Infectious Disease (2025)
- Non-invasive diagnosis of vulvar dysplasia using cervical methylation markers — a case control study: Sabeth Becker et al, BMC Medicine (2025)
- HPV-16 E6 mutation and viral integration related host DNA methylation implicate the development and progression of cervical cancer: Chenjun Huang et al, Infectious Diseases (2025)
- Performance of a six-methylation-marker assay in predicting LEEP specimen histology results of cervical HSIL patients: a retrospective study: Ruolan Wu et al, BMC Cancer (2025)
- Host Gene Methylation as a Triage Test for HPV–positive women: Vieira-Baptista P., J Low Genit Tract Dis (2024)
- Methylation Analysis to Detect CIN3+ in hrHPV positive Self-Samples: de Waard J. et al, Modern Pathology (2024)
- GynTect Methylation Markers to Detect Recurrent Disease in CIN3 Patients: Hoyer H. et al, Cancers (2024)
- Methylation analysis of host genes in CIN and CxCa samples: Shi L. et al, BMC Cancer (2023)
- CIN2/3 Lesion Regression in GynTect® -Negative Patients; a Longitudinal Study: Hoyer H. et al, Cancers (2023)
- DNA Methylation of GynTect-Markers for Diagnosis of Cervical Cancer: Fan C. et al, Cancer Management and Research (2023)
- Predictive value of GynTect Markers on HPV-positive self-samples; prospective study: Zhang L. et.al, Cancer Epidemiology (2021)
- Performance of GynTect assay on self-samples; feasibility study: Klischke et al, Journal of Virological Methods (2021)
- Comparison trial of GynTect and QIAsure: Dippmann et al, BMC (2020)
- 3q26 amplification and promoter methylation in CIN patients: Beiersdorf et al, Geneses Chromosomes Cancer (2020)
- Psychological distress in cervical cancer screening: M. Jentschke et al, Archives of Gynecology and Obstetrics (2020)
- Performance of GynTect in LBC samples; approval trial: Schmitz et al, BMC Cancer (2018)
- GynTect-Performance an STM samples: Schmitz et al, Clin Epigenetics (2017)
- Performance of GynTect in LBC samples: Eichelkraut et al, Newslab (2017)
- New DNA Methylation Signature for Triage of hrHPV women: Hansel et al., PLOS ONE (2014)
